Beam Therapeutics reported promising Phase 1/2 data for BEAM-302, demonstrating durable gene correction for AATD. See why I ...

"The change in daily sleep patterns may be intertwined with cognitive aging, and may serve as an early marker or risk factor ...

Imagine a previously unknown bug—new to our immune defenses—that suddenly emerged and rapidly spread all over the globe, ...

A research team using EST-SSR molecular marker technology reveals vital information on the genetic diversity and structure of nine natural populations of Phoebe bournei, providing a scientific ...

A JAMA Network Open study finds that better cardiovascular health (CVH) in older adults is linked to lower levels of ...

Synopsis: In a case with implications for the litigious molecular diagnostics space and written description law, Chief Judge Connolly ...

Having a better midlife diet associated with better functional connectivity between the hippocampus and both the occipital ...

Ionis and Ultragenyx are competing to develop oligonucleotide treatments for Angelman syndrome, but will Neuren’s peptide ...

PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly ...

EBV antibodies trigger MS by attacking brain proteins. Genetic factors worsen risk. Breakthrough insights for treatment.

If you've ever pictured the builders of Stonehenge or the legendary warriors immortalized in "The Iliad" and "The Odyssey," ...

Higher levels of environmental metals in urine are linked to worse cognitive performance and a greater risk of developing dementia.